siRNA treatment lowers triglycerides in patients along with unusual disorder
.STUDY HIGHLIGHT.19 September 2024.
Plozasiran minimized triglyceride amounts through 80% and also lowered the threat of pancreatitis in individuals with persistent chylomicronemia, along with or even without a hereditary prognosis.